Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility
AssigneeLek Pharmaceuticals D.D.
InventorsRok Grahek, Aleksander Resman, Andrej Bastarda, Martin Crnugelj
Life of this patent
Estimating the term…
Loading patent…
AssigneeLek Pharmaceuticals D.D.
InventorsRok Grahek, Aleksander Resman, Andrej Bastarda, Martin Crnugelj
Estimating the term…
A combination preparation comprising an active pharmaceutical ingredient (API) and a pharmaceutically acceptable solid support, wherein said solid support is in a water-insoluble particulate form and comprises a material selected from silicic acid, aluminum hydroxide and titanium hydroxide is disclosed. The API is a compound having both, at least one hydrophobic structural moiety causing the API to have a low solubility in water or in an aqueous solution, and multiple hydrophilic groups arranged to form multiple intermolecular interactions to the solid support involving polar or ionic or hydrogen bonding. The hydrophilic groups of the API are independently equal or different and comprise at least one of the groups consisting of OH- and halogen-groups. The API is bound to the solid support by adsorption, and a major proportion of said API is in an amorphous state. Related pharmaceuticals and methods of preparation also are disclosed.
A combination preparation comprising an active pharmaceutical ingredient (API) and a pharmaceutically acceptable solid support,
(canceled)
A method for producing a combination preparation comprising an active pharmaceutical ingredient (API) and a pharmaceutically acceptable solid support, the method comprising:
Dependencies are inferred from the claim text.